NCT07183358Not yet recruiting
Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer
Effect of Family-Supervised Multimodal Prehabilitation Throughout Preoperative Neoadjuvant Chemotherapy on Clinical Outcomes in Gastric Cancer Patients: A Single-Center Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study evaluates whether a family-supervised exercise-nutrition-psychology program can reduce complications after stomach-cancer surgery. Eligible patients are adults who will receive chemotherapy before surgery. Participants are randomly assigned to either the multimodal prehabilitation program plus usual care or usual care alone. The main outcome is the rate of serious complications within 30 days after surgery. Potential benefits include fewer complications and faster recovery; risks are minimal and mainly related to mild exercise fatigue.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- First submitted
- 13 Sept 2025
- Start date
- 20 Sept 2025
- Primary completion date
- 20 Mar 2026
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07183358
What you commit to
- Study type: Interventional
- Planned participants: 90
- From 20 Sept 2025 to the primary completion date, 20 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous or concurrent malignancies
- Prior major abdominal surgery (except laparoscopic cholecystectomy)
- Continuous use of NSAIDs, corticosteroids, or probiotics within 1 month
Other illness
- Emergent conditions (bleeding, perforation, obstruction) requiring immediate surgery
- Severe psychiatric disorders
- Unstable angina, myocardial infarction, or cerebrovascular event within 6 months
- Simultaneous surgery for other diseases
- Any condition that, in the investigator's opinion, contraindicates participation
Other
- Pregnant or lactating women
- FEV1 \< 50 % predicted
Who the study is looking for
- Age 18-80 years
- Histologically proven gastric adenocarcinoma by gastroscopy
- Clinical stage T2-4a, N any, M0 planned for neoadjuvant chemotherapy plus radical gastrectomy
- ECOG performance status 0-1; ASA class I-III
- Able to understand the study and provide signed informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Qingdao University Affiliated Hospital Coordinator of this site? Confirm its status | Qingdao | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.